<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37063843</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Cardiac and vascular complications in lupus: Is there a role for sex?</ArticleTitle><Pagination><StartPage>1098383</StartPage><MedlinePgn>1098383</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1098383</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1098383</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a common systemic autoimmune disorder and is characterized by autoantibody formation and subsequent immune complex deposition into target organs. SLE affects nearly nine women to every one man worldwide. Patients with SLE are at an enhanced risk for cardiovascular disease (CVD) morbidity and mortality. CVD is the leading cause of death worldwide and includes heart and blood vessel disorders, cerebrovascular disease, and rheumatic heart disease. Specific mechanisms by which cardiac and vascular pathophysiology develops in patients with SLE are still not fully known. Not only do we not understand this correlation between SLE and CVD, but there is also a critical gap in scientific knowledge on the contribution of sex. In this review, we will discuss the cardiac and vascular pathological disease states that are present in some patients with SLE. More importantly, we will discuss the potential mechanisms for the role of sex and sex hormones in the development of CVD with SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Corker, Learmonth, Patrick, DeLeon-Pennell and Van Beusecum.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corker</LastName><ForeName>Alexa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Learmonth</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrick</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research Service, Tennessee Valley Healthcare Veterans Affairs (VA) Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeLeon-Pennell</LastName><ForeName>Kristine Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research Service, Ralph H. Johnson Veterans Affairs (VA) Healthcare System, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Beusecum</LastName><ForeName>Justin P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Research Service, Ralph H. Johnson Veterans Affairs (VA) Healthcare System, Charleston, SC, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM132055</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 GM113278</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac</Keyword><Keyword MajorTopicYN="N">cardiovascular complications</Keyword><Keyword MajorTopicYN="N">lupus</Keyword><Keyword MajorTopicYN="N">sex differences</Keyword><Keyword MajorTopicYN="N">vascular</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37063843</ArticleId><ArticleId IdType="pmc">PMC10090292</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1098383</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wolf VL, Taylor EB, Ryan MJ. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus. Physiol Rep (2019) 7:e14059. doi: 10.14814/phy2.14059</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14059</ArticleId><ArticleId IdType="pmc">PMC6533177</ArticleId><ArticleId IdType="pubmed">31124322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajeganova S, Hafstrom I, Frostegard J. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus Sci Med (2021) 8. doi: 10.1136/lupus-2020-000454</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000454</ArticleId><ArticleId IdType="pmc">PMC7871345</ArticleId><ArticleId IdType="pubmed">33547230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm AJ, Major AS. Accelerated atherosclerosis in SLE: Mechanisms and prevention approaches. Int J Clin Rheumtol (2012) 7:527&#x2013;39. doi: 10.2217/ijr.12.46</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ijr.12.46</ArticleId><ArticleId IdType="pmc">PMC3963493</ArticleId><ArticleId IdType="pubmed">24672580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: The role of traditional and lupus related risk factors. Curr Cardiol Rev (2008) 4:116&#x2013;22. doi: 10.2174/157340308784245775</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157340308784245775</ArticleId><ArticleId IdType="pmc">PMC2779351</ArticleId><ArticleId IdType="pubmed">19936286</ArticleId></ArticleIdList></Reference><Reference><Citation>do Socorro Teixeira Moreira Almeida M, da Costa Arcoverde J, Barros Jacobino MN, Coimbra Neto AR. Male Systemic lupus erythematosus, an overlooked diagnosis. Clin Pract (2011) 1:e103. doi: 10.4081/cp.2011.e103</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2011.e103</ArticleId><ArticleId IdType="pmc">PMC3981404</ArticleId><ArticleId IdType="pubmed">24765344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, et al. . Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol (2014) 41:680&#x2013;7. doi: 10.3899/jrheum.130874</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.130874</ArticleId><ArticleId IdType="pmc">PMC3975689</ArticleId><ArticleId IdType="pubmed">24532834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey D, Ofori E, Hutton-Mensah KA, Akutek MLK, Okine R, Amoaba I, et al. . Clinical characteristics of males with systemic lupus erythematosus (SLE) in an inception cohort of patients in Ghana. Ghana Med J (2019) 53:2&#x2013;7. doi: 10.4314/gmj.v53i1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/gmj.v53i1.1</ArticleId><ArticleId IdType="pmc">PMC6527833</ArticleId><ArticleId IdType="pubmed">31138937</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol (2012) 2012:604892. doi: 10.1155/2012/604892</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/604892</ArticleId><ArticleId IdType="pmc">PMC3368358</ArticleId><ArticleId IdType="pubmed">22690240</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH, et al. . Sex differences in systemic lupus erythematosus: Epidemiology, clinical considerations, and disease pathogenesis. Mayo Clin Proc (2020) 95:384&#x2013;94. doi: 10.1016/j.mayocp.2019.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2019.09.012</ArticleId><ArticleId IdType="pubmed">32029091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez Sepulveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jonsen A, et al. . Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ (2019) 10:60. doi: 10.1186/s13293-019-0274-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-019-0274-2</ArticleId><ArticleId IdType="pmc">PMC6915972</ArticleId><ArticleId IdType="pubmed">31843005</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med (1978) 147:1568&#x2013;83. doi: 10.1084/jem.147.6.1568</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.147.6.1568</ArticleId><ArticleId IdType="pmc">PMC2184317</ArticleId><ArticleId IdType="pubmed">308087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao HX, Sanders E, Tieng AT, Putterman C. Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice. J Neuroimmunol (2010) 229:112&#x2013;22. doi: 10.1016/j.jneuroim.2010.07.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.07.020</ArticleId><ArticleId IdType="pubmed">20800292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill BG, Hodge B, Misischia R. Lupus nephritis in a transgender woman on cross-sex hormone therapy: A case for the role of oestrogen in systemic lupus erythematosus. Lupus (2020) 29:1807&#x2013;10. doi: 10.1177/0961203320946372</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320946372</ArticleId><ArticleId IdType="pubmed">32731807</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest (1979) 63:902&#x2013;11. doi: 10.1172/JCI109390</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI109390</ArticleId><ArticleId IdType="pmc">PMC372031</ArticleId><ArticleId IdType="pubmed">447833</ArticleId></ArticleIdList></Reference><Reference><Citation>Verthelyi D, Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun (1997) 10:115&#x2013;25. doi: 10.1006/jaut.1996.0121</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1996.0121</ArticleId><ArticleId IdType="pubmed">9185873</ArticleId></ArticleIdList></Reference><Reference><Citation>Verthelyi D, Ahmed SA. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology (1994) 135:2615&#x2013;22. doi: 10.1210/endo.135.6.7988450</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo.135.6.7988450</ArticleId><ArticleId IdType="pubmed">7988450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bynote KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Genes Immun (2008) 9:137&#x2013;52. doi: 10.1038/sj.gene.6364458</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364458</ArticleId><ArticleId IdType="pubmed">18200028</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JH, Yoachim SD, Gould KA. Estrogen receptor alpha signaling is responsible for the female sex bias in the loss of tolerance and immune cell activation induced by the lupus susceptibility locus Sle1b. Front Immunol (2020) 11:582214. doi: 10.3389/fimmu.2020.582214</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.582214</ArticleId><ArticleId IdType="pmc">PMC7683613</ArticleId><ArticleId IdType="pubmed">33240270</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkeson GS. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol (2008) 128:259&#x2013;68. doi: 10.1016/j.clim.2008.03.508</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2008.03.508</ArticleId><ArticleId IdType="pmc">PMC4778964</ArticleId><ArticleId IdType="pubmed">18514033</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, McMurray RW. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol (2007) 123:219&#x2013;26. doi: 10.1016/j.clim.2007.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2007.01.008</ArticleId><ArticleId IdType="pubmed">17336162</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackworth-Young CG, Parke AL, Morley KD, Fotherby K, Hughes GR. Sex hormones in male patients with systemic lupus erythematosus: A comparison with other disease groups. Eur J Rheumatol Inflammation (1983) 6:228&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">6439564</ArticleId></ArticleIdList></Reference><Reference><Citation>Viselli SM, Stanziale S, Shults K, Kovacs WJ, Olsen NJ. Castration alters peripheral immune function in normal male mice. Immunology (1995) 84:337&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1415104</ArticleId><ArticleId IdType="pubmed">7751013</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vollenhoven RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother (2002) 3:23&#x2013;31. doi: 10.1517/14656566.3.1.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656566.3.1.23</ArticleId><ArticleId IdType="pubmed">11772330</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vollenhoven RF, Park JL, Genovese MC, West JP. And McGuire JL. a double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus (1999) 8:181&#x2013;7. doi: 10.1191/096120399678847588</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120399678847588</ArticleId><ArticleId IdType="pubmed">10342710</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Harris VM, Cavett J, Kurien BT, Liu K, Koelsch KA, et al. . Rare X chromosome abnormalities in systemic lupus erythematosus and sjogren's syndrome. Arthritis Rheumatol (2017) 69:2187&#x2013;92. doi: 10.1002/art.40207</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40207</ArticleId><ArticleId IdType="pmc">PMC8262088</ArticleId><ArticleId IdType="pubmed">28692793</ArticleId></ArticleIdList></Reference><Reference><Citation>Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M, et al. . Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum (2008) 58:2511&#x2013;7. doi: 10.1002/art.23701</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23701</ArticleId><ArticleId IdType="pmc">PMC2824898</ArticleId><ArticleId IdType="pubmed">18668569</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa FB, Sinicato NA, Julio PR, Londe AC, Marini R, Gil-da-Silva-Lopes VL, et al. . Trisomy X in a patient with childhood-onset systemic lupus erythematosus. J Transl Autoimmun (2020) 3:100043. doi: 10.1016/j.jtauto.2020.100043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100043</ArticleId><ArticleId IdType="pmc">PMC7388342</ArticleId><ArticleId IdType="pubmed">32743524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, et al. . Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun (2013) 41:60&#x2013;71. doi: 10.1016/j.jaut.2012.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.12.006</ArticleId><ArticleId IdType="pmc">PMC3622754</ArticleId><ArticleId IdType="pubmed">23434382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyfrom S, Paneru B, Knox JJ, Cancro MP, Posso S, Buckner JH, et al. . The dynamic epigenetic regulation of the inactive X chromosome in healthy human b cells is dysregulated in lupus patients. Proc Natl Acad Sci U.S.A. (2021) 118. doi: 10.1073/pnas.2024624118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024624118</ArticleId><ArticleId IdType="pmc">PMC8214693</ArticleId><ArticleId IdType="pubmed">34103397</ArticleId></ArticleIdList></Reference><Reference><Citation>Odhams CA, Roberts AL, Vester SK, Duarte CST, Beales CT, Clarke AJ, et al. . Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in systemic lupus erythematosus. Nat Commun (2019) 10:2164. doi: 10.1038/s41467-019-10106-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10106-2</ArticleId><ArticleId IdType="pmc">PMC6520347</ArticleId><ArticleId IdType="pubmed">31092820</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrett CM, Paneru B, Sandoval-Heglund D, Wang J, Banerjee S, Sindhava V, et al. . Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases. JCI Insight (2019) 4. doi: 10.1172/jci.insight.126751</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126751</ArticleId><ArticleId IdType="pmc">PMC6483655</ArticleId><ArticleId IdType="pubmed">30944248</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, et al. . Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U.S.A. (2010) 107:15838&#x2013;43. doi:&#xa0;10.1073/pnas.1001337107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1001337107</ArticleId><ArticleId IdType="pmc">PMC2936646</ArticleId><ArticleId IdType="pubmed">20733074</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks WH, Renaudineau Y. Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus. Front Genet (2015) 6:22. doi: 10.3389/fgene.2015.00022</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2015.00022</ArticleId><ArticleId IdType="pmc">PMC4329817</ArticleId><ArticleId IdType="pubmed">25763008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen SH, Henseling F, Hennesen J, Savel H, Delahaye S, Richert L, et al. . Heterogeneous escape from X chromosome inactivation results in sex differences in type I IFN responses at the single human pDC level. Cell Rep (2020) 33:108485. doi: 10.1016/j.celrep.2020.108485</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108485</ArticleId><ArticleId IdType="pmc">PMC7833293</ArticleId><ArticleId IdType="pubmed">33296655</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, et al. . A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U.S.A. (2006) 103:9970&#x2013;5. doi:&#xa0;10.1073/pnas.0603912103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603912103</ArticleId><ArticleId IdType="pmc">PMC1502563</ArticleId><ArticleId IdType="pubmed">16777955</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GJ, Canete PF, Wang H, Medhavy A, Bones J, Roco JA, et al. . TLR7 gain-of-function genetic variation causes human lupus. Nature (2022) 605:349&#x2013;56. doi: 10.1038/s41586-022-04642-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, John S, Gordon RA, Leibler C, Kashgarian M, Bastacky S, et al. . And shlomchik MJ. b cell-intrinsic TLR9 expression is protective in murine lupus. J Clin Invest (2020) 130:3172&#x2013;87. doi: 10.1172/JCI132328</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132328</ArticleId><ArticleId IdType="pmc">PMC7260024</ArticleId><ArticleId IdType="pubmed">32191633</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham MA, Wirth JR, Naga O, Eudaly J, Gilkeson GS. Estrogen receptor alpha binding to ERE is required for full Tlr7- and Tlr9-induced inflammation. SOJ Immunol (2014) 2. doi: 10.15226/soji.2014.00107</Citation><ArticleIdList><ArticleId IdType="doi">10.15226/soji.2014.00107</ArticleId><ArticleId IdType="pmc">PMC4106444</ArticleId><ArticleId IdType="pubmed">25061615</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS. Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients. Mayo Clin Proc (2019) 94:1436&#x2013;43. doi: 10.1016/j.mayocp.2019.01.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2019.01.044</ArticleId><ArticleId IdType="pmc">PMC6711365</ArticleId><ArticleId IdType="pubmed">31303426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostopoulou M, Nikolopoulos D, Parodis I, Bertsias G. Cardiovascular disease in systemic lupus erythematosus: Recent data on epidemiology, risk factors and prevention. Curr Vasc Pharmacol (2020) 18:549&#x2013;65. doi: 10.2174/1570161118666191227101636</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161118666191227101636</ArticleId><ArticleId IdType="pubmed">31880245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Wang Y, Zhang J, Pu D, Hu N, Luo J, et al. . Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and meta-analysis. Int Immunopharmacol (2021) 94:107466. doi: 10.1016/j.intimp.2021.107466</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107466</ArticleId><ArticleId IdType="pubmed">33636561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacre K, Escoubet B, Pasquet B, Chauveheid MP, Zennaro MC, Tubach F, et al. . Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study. PloS One (2014) 9:e94511. doi: 10.1371/journal.pone.0094511</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094511</ArticleId><ArticleId IdType="pmc">PMC3983200</ArticleId><ArticleId IdType="pubmed">24722263</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziedzic-Oleksy H, Mazurek A, Bugala K, Perricone C, Drabik L, Plazak W. Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients. Reumatologia (2022) 60:165&#x2013;72. doi: 10.5114/reum.2022.117836</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2022.117836</ArticleId><ArticleId IdType="pmc">PMC9301661</ArticleId><ArticleId IdType="pubmed">35875719</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson C, Eriksson P, Bjarnegard N, Jonasson H, Stromberg T, Sjowall C, et al. . Impaired microcirculation and vascular hemodynamics in relation to macrocirculation in patients with systemic lupus erythematosus. Front Med (Lausanne) (2021) 8:722758. doi: 10.3389/fmed.2021.722758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.722758</ArticleId><ArticleId IdType="pmc">PMC8591084</ArticleId><ArticleId IdType="pubmed">34790671</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes JN, Nualnim N, Sugawara J, Sommerlad SM, Renzi CP, Tanaka H. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients. Am J Hypertens (2011) 24:1194&#x2013;200. doi: 10.1038/ajh.2011.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2011.143</ArticleId><ArticleId IdType="pubmed">21833040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z, et al. . Arterial wall dysfunction in systemic lupus erythematosus. Lupus (2009) 18:522&#x2013;9. doi: 10.1177/0961203308099625</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308099625</ArticleId><ArticleId IdType="pubmed">19395454</ArticleId></ArticleIdList></Reference><Reference><Citation>Misita CP, Moll S. Antiphospholipid antibodies. Circulation (2005) 112:e39&#x2013;44. doi: 10.1161/CIRCULATIONAHA.105.548495</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548495</ArticleId><ArticleId IdType="pubmed">16027261</ArticleId></ArticleIdList></Reference><Reference><Citation>Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, et al. . Systemic lupus international collaborating c. accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 59:176&#x2013;80. doi: 10.1002/art.23353</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23353</ArticleId><ArticleId IdType="pubmed">18240193</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson GA, Peng J, Peckham H, Radziszewska A, Butler G, Pineda-Torra I, et al. . Sex hormones drive changes in lipoprotein metabolism. iScience (2021) 24:103257. doi: 10.1016/j.isci.2021.103257</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103257</ArticleId><ArticleId IdType="pmc">PMC8567005</ArticleId><ArticleId IdType="pubmed">34761181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus (2000) 9:252&#x2013;7. doi: 10.1191/096120300680198926</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120300680198926</ArticleId><ArticleId IdType="pubmed">10866095</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis (2012) 2012:876456. doi: 10.1155/2012/876456</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/876456</ArticleId><ArticleId IdType="pmc">PMC3432322</ArticleId><ArticleId IdType="pubmed">22957213</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile-Fabris L, Hernandez-Cabrera MF, Barragan-Garfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep (2014) 16:440. doi: 10.1007/s11926-014-0440-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-014-0440-9</ArticleId><ArticleId IdType="pubmed">25023725</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Cruz D. Vasculitis in systemic lupus erythematosus. Lupus (1998) 7:270&#x2013;4. doi: 10.1191/096120398678920082</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120398678920082</ArticleId><ArticleId IdType="pubmed">9643317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson R, Catastrophic Antiphospholipid Syndrome Project G . The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol (2007) 34:346&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">17304658</ArticleId></ArticleIdList></Reference><Reference><Citation>Taraborelli M, Leuenberger L, Lazzaroni MG, Martinazzi N, Zhang W, Salmon J, et al. . FRI0408 Antiphospholipid antibodies and the risk of damage accrual in systemic lupus erythematosus. Annals of the Rheumatic Diseases (2015) 74(2):574.</Citation></Reference><Reference><Citation>Viola M, de Jager SCA, Sluijter JPG. Targeting inflammation after myocardial infarction: A therapeutic opportunity for extracellular vesicles? Int J Mol Sci (2021) 22. doi: 10.3390/ijms22157831</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157831</ArticleId><ArticleId IdType="pmc">PMC8346058</ArticleId><ArticleId IdType="pubmed">34360595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. . Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther (2022) 7:78. doi: 10.1038/s41392-022-00925-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00925-z</ArticleId><ArticleId IdType="pmc">PMC8913803</ArticleId><ArticleId IdType="pubmed">35273164</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk TA, Tsantikos E, Hibbs ML. Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol (2015) 6:550. doi: 10.3389/fimmu.2015.00550</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00550</ArticleId><ArticleId IdType="pmc">PMC4623412</ArticleId><ArticleId IdType="pubmed">26579125</ArticleId></ArticleIdList></Reference><Reference><Citation>Podolska MJ, Biermann MH, Maueroder C, Hahn J, Herrmann M. Inflammatory etiopathogenesis of systemic lupus erythematosus: an update. J Inflammation Res (2015) 8:161&#x2013;71. doi:&#xa0;10.2147/JIR.S70325</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S70325</ArticleId><ArticleId IdType="pmc">PMC4548750</ArticleId><ArticleId IdType="pubmed">26316795</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, et al. . Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation (2001) 104:1887&#x2013;93. doi: 10.1161/hc4101.097518</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc4101.097518</ArticleId><ArticleId IdType="pubmed">11602489</ArticleId></ArticleIdList></Reference><Reference><Citation>Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. . Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 349:2407&#x2013;15. doi: 10.1056/NEJMoa035611</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa035611</ArticleId><ArticleId IdType="pubmed">14681506</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, et al. . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the framingham study. Am J Epidemiol (1997) 145:408&#x2013;15. doi: 10.1093/oxfordjournals.aje.a009122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009122</ArticleId><ArticleId IdType="pubmed">9048514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tornvall P, Goransson A, Ekman J, Jarnbert-Pettersson H. Myocardial infarction in systemic lupus erythematosus: Incidence and coronary angiography findings. Angiology (2021) 72:459&#x2013;64. doi: 10.1177/0003319720985337</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003319720985337</ArticleId><ArticleId IdType="pmc">PMC8044619</ArticleId><ArticleId IdType="pubmed">33412909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Xie C, Qiao W, Fei X, Guo X, Liu H, et al. . The role of estrogen membrane receptor (G protein-coupled estrogen receptor 1) in skin inflammation induced by systemic lupus erythematosus serum IgG. Front Immunol (2017) 8:1723. doi: 10.3389/fimmu.2017.01723</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01723</ArticleId><ArticleId IdType="pmc">PMC5722986</ArticleId><ArticleId IdType="pubmed">29255468</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ (2017) 8:33. doi: 10.1186/s13293-017-0152-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-017-0152-8</ArticleId><ArticleId IdType="pmc">PMC5655818</ArticleId><ArticleId IdType="pubmed">29065927</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res (2006) 69:836&#x2013;44. doi: 10.1016/j.cardiores.2005.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2005.11.031</ArticleId><ArticleId IdType="pubmed">16403479</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension (2006) 47:1019&#x2013;26. doi: 10.1161/01.HYP.0000223064.62762.0b</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000223064.62762.0b</ArticleId><ArticleId IdType="pubmed">16651458</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy E. Estrogen signaling and cardiovascular disease. Circ Res (2011) 109:687&#x2013;96. doi: 10.1161/CIRCRESAHA.110.236687</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.110.236687</ArticleId><ArticleId IdType="pmc">PMC3398381</ArticleId><ArticleId IdType="pubmed">21885836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodzadeh S, Leber J, Zhang X, Jaisser F, Messaoudi S, Morano I, et al. . Cardiomyocyte-specific estrogen receptor alpha increases angiogenesis, lymphangiogenesis and reduces fibrosis in the female mouse heart post-myocardial infarction. J Cell Sci Ther (2014) 5:153. doi: 10.4172/2157-7013.1000153</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2157-7013.1000153</ArticleId><ArticleId IdType="pmc">PMC4070011</ArticleId><ArticleId IdType="pubmed">24977106</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE. And stampfer MJ. a prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 133:933&#x2013;41. doi: 10.7326/0003-4819-133-12-200012190-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-133-12-200012190-00008</ArticleId><ArticleId IdType="pubmed">11119394</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA (2002) 288:321&#x2013;33. doi: 10.1001/jama.288.3.321</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.3.321</ArticleId><ArticleId IdType="pubmed">12117397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynne FL, Payne JA, Cain AE, Reckelhoff JF, Khalil RA. Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats. Hypertension (2004) 43:405&#x2013;12. doi: 10.1161/01.HYP.0000111833.82664.0c</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000111833.82664.0c</ArticleId><ArticleId IdType="pubmed">14699001</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig A, Buskiewicz I, Huber SA. Age-associated changes in estrogen receptor ratios correlate with increased female susceptibility to coxsackievirus B3-induced myocarditis. Front Immunol (2017) 8:1585. doi: 10.3389/fimmu.2017.01585</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01585</ArticleId><ArticleId IdType="pmc">PMC5696718</ArticleId><ArticleId IdType="pubmed">29201031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor DE, Gould KA. Estrogen receptor alpha promotes lupus in (NZBxNZW)F1 mice in a b cell intrinsic manner. Clin Immunol (2017) 174:41&#x2013;52. doi: 10.1016/j.clim.2016.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.10.011</ArticleId><ArticleId IdType="pmc">PMC5316311</ArticleId><ArticleId IdType="pubmed">27989899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Batalla I, Vargas-Delgado ME, von Amsberg G, Janning M, Loges S. Influence of androgens on immunity to self and foreign: Effects on immunity and cancer. Front Immunol (2020) 11:1184. doi: 10.3389/fimmu.2020.01184</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01184</ArticleId><ArticleId IdType="pmc">PMC7346249</ArticleId><ArticleId IdType="pubmed">32714315</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi VE. The anti-inflammatory effects of testosterone. J Endocr Soc (2019) 3:91&#x2013;107. doi: 10.1210/js.2018-00186</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/js.2018-00186</ArticleId><ArticleId IdType="pmc">PMC6299269</ArticleId><ArticleId IdType="pubmed">30582096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamad NV, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S, et al. . The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male (2019) 22:129&#x2013;40. doi: 10.1080/13685538.2018.1482487</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2018.1482487</ArticleId><ArticleId IdType="pubmed">29925283</ArticleId></ArticleIdList></Reference><Reference><Citation>Self A, Zhang J, Corti M, Esani M. Correlation between sex hormones and dyslipidemia. American Society for Clinical Laboratory Science (2019) ascls.119.002071. doi:&#xa0;10.29074/ascls.119.002071</Citation><ArticleIdList><ArticleId IdType="doi">10.29074/ascls.119.002071</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold AP, Chen X. What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol (2009) 30:1&#x2013;9. doi: 10.1016/j.yfrne.2008.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2008.11.001</ArticleId><ArticleId IdType="pmc">PMC3282561</ArticleId><ArticleId IdType="pubmed">19028515</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chen X, McClusky R, Ruiz-Sundstrom M, Itoh Y, Umar S, et al. . The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc Res (2014) 102:375&#x2013;84. doi: 10.1093/cvr/cvu064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvu064</ArticleId><ArticleId IdType="pmc">PMC4030514</ArticleId><ArticleId IdType="pubmed">24654234</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamova B, Tian Y, Jickling G, Bushnell C, Zhan X, Liu D, et al. . The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke (2012) 43:326&#x2013;34. doi: 10.1161/STROKEAHA.111.629337</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.629337</ArticleId><ArticleId IdType="pmc">PMC3938328</ArticleId><ArticleId IdType="pubmed">22052522</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Fu Q, Cui H, Qu B, Pan W, Shen N, et al. . Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: A novel link between interferon-alpha and atherosclerosis in lupus. Arthritis Rheum (2011) 63:492&#x2013;502. doi: 10.1002/art.30165</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30165</ArticleId><ArticleId IdType="pubmed">21280004</ArticleId></ArticleIdList></Reference><Reference><Citation>Doring Y, Manthey HD, Drechsler M, Lievens D, Megens RT, Soehnlein O, et al. . Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation (2012) 125:1673&#x2013;83. doi: 10.1161/CIRCULATIONAHA.111.046755</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.046755</ArticleId><ArticleId IdType="pubmed">22388324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al. . Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med (2009) 15:623&#x2013;5. doi: 10.1038/nm.1959</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1959</ArticleId><ArticleId IdType="pmc">PMC2760083</ArticleId><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Guerin C, et al. . B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 19:1273&#x2013;80. doi: 10.1038/nm.3284</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3284</ArticleId><ArticleId IdType="pmc">PMC4042928</ArticleId><ArticleId IdType="pubmed">24037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Beusecum JP, Zhang S, Cook AK, Inscho EW. Acute toll-like receptor 4 activation impairs rat renal microvascular autoregulatory behaviour. Acta Physiol (Oxf) (2017) 221:204&#x2013;20. doi: 10.1111/apha.12899</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12899</ArticleId><ArticleId IdType="pmc">PMC5641241</ArticleId><ArticleId IdType="pubmed">28544543</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y, Chao W. Toll-like receptors and myocardial inflammation. Int J Inflam (2011) 2011:170352. doi: 10.4061/2011/170352</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/170352</ArticleId><ArticleId IdType="pmc">PMC3182762</ArticleId><ArticleId IdType="pubmed">21977329</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshikha AS, Teng XY, Kanda N, Li W, Choi SC, Abboud G, et al. . TLR7 activation accelerates cardiovascular pathology in a mouse model of lupus. Front Immunol (2022) 13:914468. doi: 10.3389/fimmu.2022.914468</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.914468</ArticleId><ArticleId IdType="pmc">PMC9289616</ArticleId><ArticleId IdType="pubmed">35860280</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosslin KL, Wiginton KL. Sex differences in disease severity among patients with systemic lupus erythematosus. Gend Med (2011) 8:365&#x2013;71. doi: 10.1016/j.genm.2011.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2011.10.003</ArticleId><ArticleId IdType="pubmed">22153881</ArticleId></ArticleIdList></Reference><Reference><Citation>Riveros Frutos A, Casas I, Rua-Figueroa I, Lopez-Longo FJ, Calvo-Alen J, Galindo M, et al. . Systemic lupus erythematosus in Spanish males: A study of the Spanish rheumatology society lupus registry (RELESSER) cohort. Lupus (2017) 26:698&#x2013;706. doi: 10.1177/0961203316673728</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316673728</ArticleId><ArticleId IdType="pubmed">27799439</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLeon-Pennell KY, Mouton AJ, Ero OK, Ma Y, Padmanabhan Iyer R, Flynn ER, et al. . LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling. Basic Res Cardiol (2018) 113:40. doi: 10.1007/s00395-018-0699-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-018-0699-5</ArticleId><ArticleId IdType="pmc">PMC6105266</ArticleId><ArticleId IdType="pubmed">30132266</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>